MA30387B1 - Inhibiteurs de la renine au traitement de l'hypertension - Google Patents

Inhibiteurs de la renine au traitement de l'hypertension

Info

Publication number
MA30387B1
MA30387B1 MA31327A MA31327A MA30387B1 MA 30387 B1 MA30387 B1 MA 30387B1 MA 31327 A MA31327 A MA 31327A MA 31327 A MA31327 A MA 31327A MA 30387 B1 MA30387 B1 MA 30387B1
Authority
MA
Morocco
Prior art keywords
methods
hypertension
treatment
renin inhibitors
interruption
Prior art date
Application number
MA31327A
Other languages
English (en)
Inventor
Andrew Satlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30387(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA30387B1 publication Critical patent/MA30387B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE DES PROCÉDÉS QUI PERMETTENT DE PRÉVENIR OU TRAITER L'HYPERTENSION OU D'EN RETARDER LA PROGRESSION, LESQUELS PROCÉDÉS CONSISTENT À ADMINISTRER À UN ANIMAL À SANG CHAUD UNE QUANTITÉ THÉRAPEUTIQUEMENT EFFICACE D'UN INHIBITEUR DE LA RÉNINE OU D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CE DERNIER. L'INVENTION PORTE AUSSI SUR DES PROCÉDÉS QUI PERMETTENT DE PRÉVENIR LES COMPLICATIONS SECONDAIRES LIÉES À L'ARRÊT DU TRAITEMENT CONTRE L'HYPERTENSION.
MA31327A 2006-04-03 2008-10-23 Inhibiteurs de la renine au traitement de l'hypertension MA30387B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03

Publications (1)

Publication Number Publication Date
MA30387B1 true MA30387B1 (fr) 2009-05-04

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31327A MA30387B1 (fr) 2006-04-03 2008-10-23 Inhibiteurs de la renine au traitement de l'hypertension

Country Status (20)

Country Link
US (1) US20090062395A1 (fr)
EP (1) EP2004167A1 (fr)
JP (1) JP2009532494A (fr)
KR (1) KR20080108515A (fr)
CN (1) CN101415413A (fr)
AU (1) AU2007234917B2 (fr)
BR (1) BRPI0710095A2 (fr)
CA (1) CA2645260A1 (fr)
CL (1) CL2007000912A1 (fr)
IL (1) IL193905A0 (fr)
MA (1) MA30387B1 (fr)
MX (1) MX2008012729A (fr)
NO (1) NO20084625L (fr)
NZ (1) NZ571251A (fr)
RU (1) RU2008143055A (fr)
SG (1) SG170830A1 (fr)
TN (1) TNSN08383A1 (fr)
TW (1) TW200806283A (fr)
WO (1) WO2007118023A1 (fr)
ZA (1) ZA200807615B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (fr) * 2008-01-11 2009-07-16 Novartis Ag Utilisation de composés organiques
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
EP2768971A1 (fr) 2011-10-20 2014-08-27 Institut National de la Santé et de la Recherche Médicale (INSERM) Méthodes de dépistage et de traitement du remodelage cardiaque
EP3956021A4 (fr) * 2019-04-18 2023-06-14 EyePoint Pharmaceuticals, Inc. Méthode de traitement de l'hypertension avec des activateurs de tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
AU2003250858A1 (en) * 2002-06-28 2004-01-19 Novartis Ag Use of organic compounds
WO2004100871A2 (fr) * 2003-05-09 2004-11-25 Pharmacia Corporation Combinaison d'un antagoniste du recepteur de l'aldosterone et d'un inhibiteur de renine
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
MY144477A (en) * 2004-03-17 2011-09-30 Novartis Ag Galenic formulations of organic compounds
CA2581927C (fr) * 2004-09-27 2013-04-09 Pantarhei Bioscience B.V. Traitement preventif contre les saignements imprevus chez les femmes sous traitement contenant un progestogene

Also Published As

Publication number Publication date
AU2007234917B2 (en) 2011-05-12
WO2007118023A1 (fr) 2007-10-18
IL193905A0 (en) 2009-08-03
JP2009532494A (ja) 2009-09-10
TNSN08383A1 (en) 2009-12-29
TW200806283A (en) 2008-02-01
RU2008143055A (ru) 2010-05-10
SG170830A1 (en) 2011-05-30
ZA200807615B (en) 2009-10-28
US20090062395A1 (en) 2009-03-05
AU2007234917A1 (en) 2007-10-18
EP2004167A1 (fr) 2008-12-24
NZ571251A (en) 2011-12-22
MX2008012729A (es) 2008-10-14
CL2007000912A1 (es) 2008-03-14
KR20080108515A (ko) 2008-12-15
NO20084625L (no) 2008-11-03
CN101415413A (zh) 2009-04-22
BRPI0710095A2 (pt) 2011-08-02
CA2645260A1 (fr) 2007-10-18

Similar Documents

Publication Publication Date Title
MX2022000397A (es) Inhibidores peptídicos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
MX360150B (es) Antagonista del receptor de angiotensina ii para la prevencion o el tratamiento de enfermedades generalizadas en gatos.
ZA200703002B (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
EA202192528A1 (ru) Комбинация ингибиторов pd-1 и ингибиторов lag-3 для повышения эффективности при лечении рака
WO2007067976A3 (fr) Procédé d&#39;utilisation d&#39;antagonistes de l&#39;il-6 en association avec des inihibiteurs de protéasome
MX2009004984A (es) Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina.
WO2007115289A8 (fr) Combinaisons d&#39;agents thérapeutiques destinées à traiter le cancer
MX2010008397A (es) Inhibidores del receptor de quimioquinas cxcr3.
EA200970512A1 (ru) Лечение по поводу множественной миеломы
WO2005117846A3 (fr) Traitement de maladies a l&#39;aide d&#39;inhibiteurs de l&#39;ice
MX2021000051A (es) Inhibidores de triazol glicolato oxidasa.
MX2022002398A (es) Formas cristalinas de un inhibidor de cd73.
MA33739B1 (fr) Procédés et compositions pour traiter des tumeurs solides et d&#39;autres malignités
WO2008011114A3 (fr) Inhibiteurs de la méthionine aminopeptidase-2 et leurs procédés d&#39;utilisation
WO2007140317A3 (fr) Méthodes d&#39;utilisation d&#39;inhibiteurs de la phospholipase a2 cytosolique dans le traitement de la thrombose
ATE526953T1 (de) Verwendung von 5-ht7-rezeptor-agonisten zur behandlung von schmerzen
WO2007056324A3 (fr) Combinaison de composes organiques pour le traitement des maladies cardiovasculaires
TN2011000459A1 (en) Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
WO2007019153A3 (fr) Methodes de traitement de l&#39;hypertension
TNSN08383A1 (en) Renin inhibitors for the treatment of hypertension
MX2007004020A (es) Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica.
WO2010005585A3 (fr) Promédicaments à base de 4-aminoquinazoline
MA32933B1 (fr) Combinaison d&#39;inhibiteurs de hspo90 et d&#39;herceptine
EA202192237A1 (ru) Кристаллические формы ингибитора jak2
TW200806284A (en) Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma